MREO
Mereo BioPharma Group plc
Company Overview
| Mkt Cap | $325.81M | Price | $1.90 |
| Volume | 689.81K | Change | +0.53% |
| P/E Ratio | -- | Open | $1.90 |
| Revenue | -- | Prev Close | $1.89 |
| Net Income | -- | 52W Range | $1.47 - $4.40 |
| Div Yield | N/A | Target | $7.13 |
| Overall | 23 | Value | -- |
| Quality | 21 | Technical | 25 |
No chart data available
Stock Overview
Updated DailyMereo BioPharma Group plc (MREO) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.90 with a market capitalization of $325.81 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 21.
Today's trading session shows MREO with a volume of 690K shares. The stock opened up 0.53% from yesterday's close of $1.89. Current analyst estimates project earnings of $-0.02 per share for this year, with next year targeting $0.
MREO demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for MREO include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 275.3%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:33 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MREO | $1.90 | +0.5% | 689.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mereo BioPharma Group plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW